Global Progesterone Market - WishTree Insight

Global Progesterone Market by Type (Natural Progesterone and Synthetic Progesterone), Application (Dysfunctional Uterine Bleeding, Regulation of Menstrual Cycle, Contraception, Endometrial Cancer, and Hyperplastic Precursor Lesions), and Regions, The Asia Pacific, Middle East Africa, Europe, North America, and Latin America) - Global Industry Analysis, Share, Growth, Trends, Size, and Forecast 2021 – 2031

The Progesterone market size was valued at USD XX billion in 2021 and is expected to surpass USD XX billion by 2031, expanding at a CAGR of 13.2 % during the forecast period, 2021–2031. The market's growth is attributed to the growing incidences of diseases.

INTRODUCTION

Progesterone is a naturally occurring steroid hormone. It is produced by the adrenal glands, placenta, and ovary. Progesterone is helpful in pregnancy, regulation of the menstrual cycle, and embryogenesis. Low progesterone can cause abdominal pain, constant breast tenderness, miscarriage or fetal death, and fatigue. To recover this phase progesterone is given to the diseased patient to prevent the aforementioned conditions.

Market Trends, Drivers, Restraints, and Opportunities

• Growing incidences of diseases such as abnormal uterine bleeding, kidney, breast, amenorrhea, uterine cancer, and other diseases are the factors that are driving the growth of global progesterone.
• The technological advancements in the medical industry, synthetic progesterone or progestins are expected to propel the market.
• Lack of awareness regarding the availability of hormone therapy and side effects of progesterone are expected to hinder the market.

Scope of the Report

Market Segment Insights

Based on type, the progesterone market is divided into natural progesterone and synthetic progesterone.

Based on application, the progesterone market is divided into dysfunctional uterine bleeding, regulation of the menstrual cycle, contraception, endometrial cancer, and hyperplastic precursor lesions.

The North American region dominates the market share

In terms of regions, the progesterone market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of the North American region dominates the market owing to increasing incidences of menstrual cycle issues, rising consumption of progestin & progesterone, lifestyle disorders, technological advancements, and hormonal replacement. However, the market of the Asia pacific is anticipated to expand at a rapid pace during the forecast period. The growth in the region is attributed to the increasing prevalence of chronic diseases and infertility in the region.

Competitive Landscape

Key players competing in the Progesterone market are Sofgen Pharmaceuticals Industries Ltd. (U.S.); Blubell Pharma Group Company (India); Aquatic Remedies Pvt. Ltd (India); Intas Pharmaceuticals Ltd. (India); Teva Pharmaceuticals Industries Ltd. (Israel).

FAQs

During the forecast period, what is the CAGR of the market?

During the forecast period, the CAGR of the market is expected to be 13.2%.

What are the key drivers of the market?

The market's growth is attributed to the growing incidences of diseases.

What segments are covered in the Progesterone report?

The segments covered in the report are type (natural progesterone and synthetic progesterone), application (dysfunctional uterine bleeding, regulation of menstrual cycle, contraception, endometrial cancer, and hyperplastic precursor lesions).

Mention which region is expected to hold the highest share of the Progesterone market.

The North American region is expected to hold the highest share of the Progesterone market.

Mention the key players in the market.

Sofgen Pharmaceuticals Industries Ltd. (U.S.); Blubell Pharma Group Company (India); Aquatic Remedies Pvt. Ltd (India); Intas Pharmaceuticals Ltd. (India); Teva Pharmaceuticals Industries Ltd. (Israel)